| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | FMR Inc | 65.78M (12.06%) | 5.01M Increased by +7.62% | Dec 31, 25 |
| 2 | Morgan Stanley - Brokerage Accounts | 58.36M (10.70%) | 14.04M Increased by +24.05% | Dec 31, 25 |
| 3 | Vanguard Group Inc | 42.06M (7.71%) | 3.25M Increased by +7.74% | Dec 31, 25 |
| 4 | BlackRock Inc | 41.17M (7.55%) | 1.45M Increased by +3.51% | Dec 31, 25 |
| 5 | Qvt Financial LP | 29.38M (5.39%) | 0.00 Increased by 0.00% | Sep 30, 25 |
| 6 | UBS Group AG | 22.62M (4.15%) | 4.23M Increased by +18.69% | Mar 31, 26 |
| 7 | State Street Corp | 17.36M (3.18%) | -1.34M Decreased by -7.71% | Dec 31, 25 |
| 8 | State Street Corporation | 17.15M (3.14%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 9 | SB INVESTMENT ADVISERS (UK) LTD | 16.41M (3.01%) | -23.90M Decreased by -145.62% | Dec 31, 25 |
| 10 | Wellington Management Company LLP | 13.64M (2.50%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 11 | Patient Square Capital | 12.48M (2.29%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 12 | The Goldman Sachs Group Inc | 10.98M (2.01%) | 8.62M Increased by +78.50% | Dec 31, 25 |
| 13 | Adage Capital Partners Gp LLC | 10.68M (1.96%) | 3.45M Increased by +32.27% | Dec 31, 25 |
| 14 | T. Rowe Price Investment Management,Inc. | 10.65M (1.95%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 15 | Two Seas Capital LP | 9.79M (1.79%) | -1.96M Decreased by -20.04% | Dec 31, 25 |
| 16 | Patient Square Capital LP | 8.17M (1.50%) | 0.00 Increased by 0.00% | Mar 31, 26 |
| 17 | Geode Capital Management, LLC | 8.15M (1.49%) | -49.05K Decreased by -0.60% | Dec 31, 25 |
| 18 | Dimensional Fund Advisors, Inc. | 7.48M (1.37%) | -1.77M Decreased by -23.70% | Mar 31, 26 |
| 19 | Perceptive Advisors LLC | 7.37M (1.35%) | 4.04M Increased by +54.79% | Sep 30, 25 |
| 20 | Farallon Capital Management, L.L.C. | 7.34M (1.34%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 29.08M (5.33%) | 419.32K Increased by +1.44% | Mar 31, 26 |
| 2 | Fidelity Growth Company Fund | 22.06M (4.04%) | 283.00K Increased by +1.28% | Mar 31, 26 |
| 3 | Fidelity Growth Compy Commingled Pl O | 21.15M (3.88%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 4 | iShares Core S&P Mid-Cap ETF | 15.22M (2.79%) | -7.66K Decreased by -0.05% | Apr 30, 26 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 14.80M (2.71%) | 358.33K Increased by +2.42% | Mar 31, 26 |
| 6 | Vanguard US Total Market Shares ETF | 14.26M (2.61%) | 14.26M Increased by +100.00% | Sep 30, 24 |
| 7 | Fidelity® Growth Company | 10.84M (1.99%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Small Cap Index | 10.74M (1.97%) | 471.21K Increased by +4.39% | Mar 31, 26 |
| 9 | Vanguard Health Care Inv | 9.57M (1.75%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 10 | SPDR® S&P Biotech ETF | 7.21M (1.32%) | 16.07K Increased by +0.22% | Aug 31, 25 |
| 11 | Morgan Stanley Growth | 6.37M (1.17%) | 1.09M Increased by +17.07% | Dec 31, 25 |
| 12 | Morgan Stanley Growth SMA | 6.37M (1.17%) | 1.09M Increased by +17.07% | Dec 31, 25 |
| 13 | Morgan Stanley Inst Growth I | 6.37M (1.17%) | 1.09M Increased by +17.07% | Dec 31, 25 |
| 14 | Fidelity Growth Company K6 | 6.14M (1.13%) | 31.98K Increased by +0.52% | Mar 31, 26 |
| 15 | Invesco S&P MidCap Quality ETF | 6.02M (1.10%) | 0.00 Increased by 0.00% | May 30, 25 |
| 16 | Vanguard Small Cap Growth Index Inv | 6.01M (1.10%) | 313.03K Increased by +5.21% | Mar 31, 26 |
| 17 | Fidelity Series Growth Company | 5.73M (1.05%) | 198.30K Increased by +3.46% | Mar 31, 26 |
| 18 | MS INVF US Advantage I | 5.31M (0.97%) | -375.50K Decreased by -7.08% | Mar 31, 26 |
| 19 | T. Rowe Price Mid-Cap Growth | 5.25M (0.96%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 20 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (0.96%) | 5.25M Increased by +100.00% | Sep 30, 23 |